TP53 and neoplasm: The NGS analysis with the Oncopan Panel, on both the tumor specimens, revealed the presence of the TP53 variant c.742C>T p.(Arg248Trp), in 47% of reads (907/1930) in one sample (T1) and 56% (1015/1820) in the other (T2) (Figure 4).